Home › Funds › Renaissance Technologies › DYN
Renaissance Technologies position in DYN
DYNE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)360.57K sh
Reported value held$8.01M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 140.50K | $2.28M | New |
| Q4 2021 | 68.50K | $814.00K | Reduce |
| Q1 2022 | 42.70K | $412.00K | Reduce |
| Q2 2022 | 91.20K | $627.00K | Add |
| Q3 2022 | 104.90K | $1.33M | Add |
| Q4 2022 | 107.70K | $1.25K | Add |
| Q1 2023 | 73.30K | $844 | Reduce |
| Q2 2024 | 126.00K | $4.45M | New |
| Q3 2025 | 345.50K | $4.37M | New |
| Q4 2025 | 470.64K | $9.21M | Add |
| Q1 2026 | 533.60K | $9.67M | Add |
| Q2 2026 | 360.57K | $8.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DYN
- BlackRock Inc 12.40M sh · $275.50M · Q2 2026
- Fidelity Management & Research (FMR) 11.21M sh · $248.91M · Q2 2026
- Janus Henderson Group 13.65M sh · $247.43M · Q1 2026
- Vanguard Group 11.22M sh · $219.38M · Q4 2025
- Geode Capital Management 3.74M sh · $83.16M · Q2 2026
- JPMorgan Chase & Co 3.15M sh · $67.15M · Q2 2026
- Bank of America Corp 2.23M sh · $49.60M · Q2 2026
- Goldman Sachs Group 2.16M sh · $47.91M · Q2 2026
- Franklin Resources 2.03M sh · $45.10M · Q2 2026
- Marshall Wace 1.49M sh · $33.07M · Q2 2026
- Northern Trust Corp 1.28M sh · $28.39M · Q2 2026
- Charles Schwab Investment Management 1.20M sh · $26.70M · Q2 2026